Cherry had "no route to treatment until after the birth," of a child while carrying her second baby in 2022, the singer recalled in a press release on Tuesday, reported Page Six, a US-based media company.
Experiments on mice and human cells reveal that the number of specialised immune cells ready to combat skin cancer increased when a novel therapy prevented their egress from melanoma tumours.
Researchers from UCL Cancer Center have offered essential molecular insights into how an injury may lead to the formation of glioma, a relatively rare but typically aggressive kind of brain tumour.
A very uncommon but frequently aggressive type of brain tumour called a glioma may be caused by damage, according to key molecular research from the UCL Cancer Centre. Although there may be a connection between head trauma and an increase in brain tumour incidence, the evidence is conflictin
A small but significant metabolic difference between human and mouse lung tumour cells, has been discovered by Weill Cornell Medicine researchers, explaining a discrepancy in previous study results, and pointing toward new strategies for developing cancer treatments.
he UCL Cancer Center researchers have offered essential molecular insights of how injury may lead to the formation of glioma, a relatively rare but typically aggressive kind of brain tumour.
Researching the wall separating the circulatory system from the neurological system has been highly difficult or limited in its use of models. In order to properly investigate potential new treatments for brain tumours, researchers have created a more realistic model.
Scientists at the University of East Anglia are a step closer to creating a new generation of light-activated cancer treatments. The procedure, which sounds futuristic, would function by turning on embedded LED lights adjacent to a tumour, which would then activate biotherapeutic chemicals.
Researchers have discovered a previously unidentified function of "natural killer" (NK) immune cells, which has increased our understanding of how the immune system is controlled to prevent disease.
Gene mutations are the cause of cancer. Tumor suppressors and oncogenes are the two main groups of these altered genes in cancer. Mutations in oncogenes can drive cell proliferation, pushing the gas pedal all the way to the floor, whereas mutations in tumour suppressor genes can cause tumour
CAR T-cell therapy, a sort of cancer treatment in which the immune system's T cells are trained to attack tumour cells, was found to be effective in mice with ovarian cancer, according to a study.
Cancer is a disease driven by gene mutations. These mutated genes in cancer fall into two major categories: tumour suppressors and oncogenes. Mutations in tumour suppressor genes can allow tumours to grow unchecked - a case of no brakes - while mutations in oncogenes can activate cell prolif